July 2, 2021 by Fightec.org
https://www.businesswire.com/news/home/20210701005834/en/Merck-Provides-Update-on-KEYTRUDA%C2%AE-pembrolizumab-Indication-in-Third-Line-Gastric-Cancer-in-the-US